Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.
Oxygen cost of walking in persons with multiple sclerosis: disability matters, but why?
The endocannabinoid system: a putative role in neurodegenerative diseases.
Comparison of regular aerobic and yoga on the quality of life in patients with multiple sclerosis.
Differential patterns of spinal cord and brain atrophy in NMO and MS.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Corrigendum: "High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II - The Total Macular Volume. The First Follow-Up Study Over 2 Years".
Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitis.
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association?
JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis.
Transverse Myelitis Associated with Anti-Ro (SSA) Autoantibodies: A Record of Two Cases.
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study.
Multiple sclerosis patients and clinical care in Taiwan.
Optic neuritis: A blurry issue.
Cognitive impairment and optic nerve axonal loss in patients with clinically isolated syndrome.
Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant multiple sclerosis.
Accurately diagnosing and comprehensively managing MS.
The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.
Epstein-Barr virus and multiple sclerosis: association or causation?
New magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis.
Diffuse multiple sclerosis and chronic central serous chorioretinopathy: pitfall not to ignore.
Exploring the role of interleukin-22 in neurological and autoimmune disorders.
Association between age at onset of multiple sclerosis and vitamin D level-related factors.
Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study.
Pages
« first
‹ previous
…
361
362
363
364
365
366
367
368
369
…
next ›
last »